Transcenta Holding Limited (HKG:6628)
Hong Kong · Delayed Price · Currency is HKD 0.9750
+0.1450 (17.47%)
Sep 18, 2026, 4:08 PM HKT
Transcenta Holding Employees
Transcenta Holding had 150 employees as of June 30, 2026. The number of employees decreased by 5 or -3.23% since the number was reported on December 31, 2025.
Employees
150
Change
-5
Growth
-3.23%
Revenue / Employee
217.97K HKD
Profits / Employee
-1.24M HKD
Market Cap
415.98M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 150 | -5 | -3.23% |
| Dec 31, 2025 | 155 | -29 | -15.76% |
| Dec 31, 2024 | 184 | -31 | -14.42% |
| Dec 31, 2023 | 215 | -105 | -32.81% |
| Dec 31, 2022 | 320 | -43 | -11.85% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Uni-Bio Science Group | 568 |
| JW (Cayman) Therapeutics Co. | 303 |
| Cutia Therapeutics | 268 |
| Immunotech Biopharm | 189 |
| 3D Medicines | 162 |
| Kintor Pharmaceutical | 122 |
| Brii Biosciences | 80 |
| Wuhan YZY Biopharma | 68 |
Transcenta Holding News
- 8 months ago - Transcenta Collaborates With EirGenix To License HiCB Platform - Nasdaq